Literature DB >> 1561395

An overview of clinical spectrum and heterogeneity of spondyloarthropathies.

M A Khan1.   

Abstract

Ankylosing spondylitis and related spondyloarthropathies form a family of rheumatic diseases that are characterized by inflammatory peripheral and axial arthritis, with predilection for sacroiliitis, and a remarkably strong association with a genetic marker, HLA-B27. The association with B27 has provided a great impetus to the epidemiologic studies of spondyloarthropathies and also helped broaden the clinical spectrum of these diseases. There are at least six subtypes of B27, and the x-ray crystallographic structure of the common B27 subtype (B*2705) is now known. Endogenous peptides bound in the B27 antigen-binding cleft have been isolated and all seem to be nonamers (i.e., nine amino acids long).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1561395

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  17 in total

1.  [Bactericidal permeability increasing protein (BPI-ANCA marked chronic inflammatory bowel diseases and hepatobiliary diseases].

Authors:  A Schnabel; E Csernok; H Schultz; M Stoffel; C Herzberg; S F Carroll; W L Gross
Journal:  Med Klin (Munich)       Date:  1997-07-15

2.  Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide.

Authors:  R A Colbert; S L Rowland-Jones; A J McMichael; J A Frelinger
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

3.  Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis.

Authors:  C Fendler; S Laitko; H Sörensen; C Gripenberg-Lerche; A Groh; J Uksila; K Granfors; J Braun; J Sieper
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

4.  Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies.

Authors:  J D Cañete; S E Martínez; J Farrés; R Sanmartí; M Blay; A Gómez; G Salvador; J Muñoz-Gómez
Journal:  Ann Rheum Dis       Date:  2000-04       Impact factor: 19.103

5.  Commented glossary for rheumatic spinal diseases.

Authors:  J Braun; J Sieper
Journal:  Ann Rheum Dis       Date:  1996-01       Impact factor: 19.103

6.  Efficacy of golimumab on recurrent uveitis in HLA-B27-positive ankylosing spondylitis.

Authors:  Serpil Yazgan; Ugur Celik; Metin Işık; Nesibe Karahan Yeşil; Ali Erdem Baki; Hatice Şahin; Ercan Gencer; İsmail Doğan
Journal:  Int Ophthalmol       Date:  2016-05-06       Impact factor: 2.031

Review 7.  Pathways of cell activation in spondyloarthropathies.

Authors:  U Fearon; D J Veale
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

8.  Efficiency of adalimumab, etanercept and infliximab in ankylosing spondylitis in clinical practice.

Authors:  Vicente Escudero-Vilaplana; Esther Ramírez-Herráiz; Estefanía Alañón-Plaza; Nicolás Trovato-López; Rosario García-Vicuña; Luis Carreño-Pérez; Alberto Morell-Baladrón; María Sanjurjo-Sáez
Journal:  Int J Clin Pharm       Date:  2015-04-25

Review 9.  Genetic background and environment contribute synergistically to the onset of autoimmune diseases.

Authors:  P Luppi; M R Rossiello; S Faas; M Trucco
Journal:  J Mol Med (Berl)       Date:  1995-08       Impact factor: 4.599

Review 10.  The pathogenetic aspects of spondyloarthropathies from the point of view of HLA-B27.

Authors:  H Kellner; D Yu
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.